Screener
Sarepta Therapeutics, Inc. SRPT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208893
FAQ
- What is Sarepta Therapeutics, Inc.'s free cash flow?
- Sarepta Therapeutics, Inc. (SRPT) reported free cash flow of -$204.76M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s free cash flow changed year-over-year?
- Sarepta Therapeutics, Inc.'s free cash flow increased by 67.3% year-over-year, from -$627.09M to -$204.76M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s free cash flow?
- Over 2 years (2021 to 2023), Sarepta Therapeutics, Inc.'s free cash flow has grown at a 9.5% compound annual growth rate (CAGR), from -$481.66M to -$577.1M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Sarepta Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude